Back to Journals » Drug Design, Development and Therapy » Volume 11

Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials [Corrigendum]

Authors Toussirot E, Vauchy C, Binda D, Michel F

Received 28 November 2016

Accepted for publication 28 November 2016

Published 11 January 2017 Volume 2017:11 Pages 175—176

DOI https://doi.org/10.2147/DDDT.S128869

Toussirot E, Vauchy C, Binda D, Michel F. Drug Des Devel Ther. 2016;10:2087–2094.

On page 2089, a column heading in Table 1 was incorrectly presented. The last column heading was presented as “Golimumab 60 mg”, whereas this should have been presented as “Golimumab 100 mg” as shown below:

Read the original article

 

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Golimumab in radiographic and nonradiographic axial spondyloarthritis: a review of clinical trials

Toussirot E, Vauchy C, Binda D, Michel F

Drug Design, Development and Therapy 2016, 10:2087-2094

Published Date: 1 July 2016

Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement

Toussirot E, Michel F, Béreau M, Binda D

Patient Preference and Adherence 2013, 7:369-377

Published Date: 26 April 2013

Management of ankylosing spondylitis with infliximab

Éric Toussirot, Ewa Bertolini, Daniel Wendling

Open Access Rheumatology: Research and Reviews 2009, 1:69-82

Published Date: 18 June 2009